Adnan R. Munkarah, MD
Chairman, Dept of Women's Health Services
Henry Ford Health System
Dept. of OB/GYN
3031 W. Grand Blvd.
7th Floor/ WHS Admin Suite
Detroit,
MI
USA
48202-3141
Papers:
41
Synthetic lethality of PARP inhibitors and metformin in BRCA1 intact ovarian cancer
79
Impact of surgical staging and adjuvant therapy on recurrence risk and outcome in stage I non-invasive uterine papillary serous carcinoma
283
Heterogeneity of energy dynamics in ovarian cancer cell lines
404
Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma
442
Bioenergetic adaptations in chemo-resistant ovarian cancer cells
445
Association of AMPK signaling pathway with tumor response to treatment in ovarian cancer
454
Association of high-density lipoprotein cholesterol with ovarian cancer diagnosis
465
Factors affecting ovarian cancer treatment in the octogenarian patient population
Robotic resection of localized persistent ovarian cancer in the aortocaval region